The translational landscape of mTOR signalling steers cancer initiation and metastasis
What this study shows
Showed WHY mTOR-driven translation matters for cancer: in prostate cancer, oncogenic mTOR selectively translates a specific set of pro-invasion mRNAs that drive metastasis. An ATP-competitive mTOR inhibitor (INK128) reversed that signature - an early preclinical rationale from mouse models and cell lines, not a clinical result.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Mouse models + human prostate cancer) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Mouse models + human prostate cancer |
| Journal | Nature |
| Year | 2012 |
| Peer reviewed | Yes |
| Record last updated | 2026-07-29 |
| Source | DOI 10.1038/nature10912 · PMID 22367541 · Free full text (PMC3663483) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Oncogenic mTOR modulation + ribosome profiling |
| Target | mTOR / 4E-BP–eIF4E translation |
| Model | Mouse models + human prostate cancer |
| Effect | Oncogenic mTOR reprograms translation of a specific gene set driving proliferation, metabolism and invasion/metastasis |
In the Atlas
Related topics
Links in the pathway map
- Supports eIF4E activates Protein synthesis
- Supports mTORC1 activates Tumor growth
- Supports mTORC1 activates Ribosome biogenesis
- Supports mTORC1 activates 5'TOP mRNA
More studies on this topic
- mTOR inactivation governs adaptive survival to ribosome biogenesis deficiency (2026)
- mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice (2009)
- TORC1 and PKA activity towards ribosome biogenesis oscillates in synchrony with the budding yeast cell cycle (2022)
- mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways (2004)
Was this page useful?
Thank you. Your answer was counted anonymously.